Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway

Cancer Gene Therapy, Published online: 13 March 2024; doi:10.1038/s41417-024-00760-0Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway

https://www.nature.com/articles/s41417-024-00760-0

Source: Cancer Gene Therapy - March 13, 2024 Category: Cancer & Oncology Authors: Wei-Feng Xia Xiao-Li Zheng Wen-Yi Liu Yu-Tang Huang Chun-Jie Wen Hong-Hao Zhou Qing-Chen Wu Lan-Xiang Wu Source Type: research